Denton David M 4
4 · PFIZER INC · Filed Jun 1, 2022
Insider Transaction Report
Form 4
PFIZER INCPFE
Denton David M
Chief Financial Officer & EVP
Transactions
- Award
Common Stock
2022-05-31+61,275→ 62,165 total - Award
Stock Appreciation Rights
2022-05-31+80,703→ 80,703 totalExercise: $53.04From: 2027-05-31Exp: 2027-05-31→ Common Stock (80,703 underlying) - Award
Stock Appreciation Rights
2022-05-31+70,313→ 70,313 totalExercise: $53.04From: 2029-05-31Exp: 2029-05-31→ Common Stock (70,313 underlying)
Footnotes (3)
- [F1]The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
- [F2]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
- [F3]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.